| Treatment of HCV infection by targeting microRNA HLA Janssen, HW Reesink, EJ Lawitz, S Zeuzem, M Rodriguez-Torres, ... New England Journal of Medicine 368 (18), 1685-1694, 2013 | 2531 | 2013 |
| Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors MMJ Nielen, D van Schaardenburg, HW Reesink, RJ Van de Stadt, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 2427 | 2004 |
| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2075 | 2017 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1491 | 2018 |
| Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection JG McHutchison, GT Everson, SC Gordon, IM Jacobson, M Sulkowski, ... New England Journal of Medicine 360 (18), 1827-1838, 2009 | 1416 | 2009 |
| A proposed system for the nomenclature of hepatitis C viral genotypes P Simmonds, A Alberti, HJ Alter, F Bonino, DW Bradley, C Brechot, ... Hepatology 19 (5), 1321-1324, 1994 | 1347 | 1994 |
| Response-guided telaprevir combination treatment for hepatitis C virus infection KE Sherman, SL Flamm, NH Afdhal, DR Nelson, MS Sulkowski, ... New England Journal of Medicine 365 (11), 1014-1024, 2011 | 1044 | 2011 |
| Sofosbuvir and ribavirin in HCV genotypes 2 and 3 S Zeuzem, GM Dusheiko, R Salupere, A Mangia, R Flisiak, RH Hyland, ... New England Journal of Medicine 370 (21), 1993-2001, 2014 | 1022 | 2014 |
| Telaprevir for previously treated chronic HCV infection JG McHutchison, MP Manns, AJ Muir, NA Terrault, IM Jacobson, ... New England Journal of Medicine 362 (14), 1292-1303, 2010 | 945 | 2010 |
| Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B … VCW Wong, HW Reesink, HMH Ip, PN Lelie, EE Reerink-Brongers, ... The Lancet 323 (8383), 921-926, 1984 | 810* | 1984 |
| Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir C Sarrazin, TL Kieffer, D Bartels, B Hanzelka, U Müh, M Welker, ... Gastroenterology 132 (5), 1767-1777, 2007 | 770 | 2007 |
| Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay CL Van der Poel, HW Reesink, JJP van Boven, HTM Cuypers, I Winkel, ... The Lancet 337 (8737), 317-319, 1991 | 660 | 1991 |
| ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype … P Andreone, MG Colombo, JV Enejosa, I Koksal, P Ferenci, A Maieron, ... Gastroenterology 147 (2), 359-365. e1, 2014 | 545 | 2014 |
| Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study HW Reesink, S Zeuzem, CJ Weegink, N Forestier, A Van Vliet, ... Gastroenterology 131 (4), 997-1002, 2006 | 524 | 2006 |
| Reliability of polymerase chain reaction for detection of hepatitis C virus HL Zaaijer, HTM Cuypers, HW Reesink, IN Winkel, PN Lelie, G Gerken The Lancet 341 (8847), 722-724, 1993 | 499 | 1993 |
| Telaprevir and pegylated interferon–alpha‐2a inhibit wild‐type and resistant genotype 1 hepatitis C virus replication in patients TL Kieffer, C Sarrazin, JS Miller, MW Welker, N Forestier, HW Reesink, ... Hepatology 46 (3), 631-639, 2007 | 470 | 2007 |
| Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study G Dusheiko, J Main, H Thomas, O Reichard, C Lee, A Dhillon, S Rassam, ... Journal of hepatology 25 (5), 591-598, 1996 | 449 | 1996 |
| Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands CL Van der Poel, PN Lelie, QL Choo, HW Reesink, AL Vaar-Kuypers, ... The Lancet 334 (8658), 297-298, 1989 | 391 | 1989 |
| Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis VP Van Halm, MMJ Nielen, MT Nurmohamed, D Van Schaardenburg, ... Annals of the rheumatic diseases 66 (2), 184-188, 2007 | 372 | 2007 |
| Infectivity of blood seropositive for hepatitis C virus antibodies CL Van der Poel, HW Reesink, W Schaasberg, E Bakker, PJ Exel-Oehlers, ... The Lancet 335 (8689), 558-560, 1990 | 345 | 1990 |
